» Articles » PMID: 37261440

Aldehyde Dehydrogenase, a Marker of Normal and Malignant Stem Cells, Typifies Mesenchymal Progenitors in Perivascular Niches

Abstract

Innate mesenchymal stem cells exhibiting multilineage differentiation and tissue (re)generative-or pathogenic-properties reside in perivascular niches. Subsets of these progenitors are committed to either osteo-, adipo-, or fibrogenesis, suggesting the existence of a developmental organization in blood vessel walls. We evaluated herein the activity of aldehyde dehydrogenase, a family of enzymes catalyzing the oxidation of aldehydes into carboxylic acids and a reported biomarker of normal and malignant stem cells, within human adipose tissue perivascular areas. A progression of ALDHLow to ALDHHigh CD34+ cells was identified in the tunica adventitia. Mesenchymal stem cell potential was confined to ALDHHigh cells, as assessed by proliferation and multilineage differentiation in vitro of cells sorted by flow cytometry with a fluorescent ALDH substrate. RNA sequencing confirmed and validated that ALDHHigh cells have a progenitor cell phenotype and provided evidence that the main isoform in this fraction is ALDH1A1, which was confirmed by immunohistochemistry. This demonstrates that ALDH activity, which marks hematopoietic progenitors and stem cells in diverse malignant tumors, also typifies native, blood vessel resident mesenchymal stem cells.

Citing Articles

Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.

Chen S, Liang B, Xu J J Transl Med. 2024; 22(1):459.

PMID: 38750573 PMC: 11094970. DOI: 10.1186/s12967-024-05294-5.


Isolation of Perivascular Mesenchymal Progenitor Cells from Human Adipose Tissue by Flow Cytometry.

Thottappillil N, Gomez-Salazar M, Archer M, Peault B, James A Methods Mol Biol. 2024; 2783:25-33.

PMID: 38478224 DOI: 10.1007/978-1-0716-3762-3_3.


Editorial: Chondrogenic potentials, protocols and mechanisms of mesenchymal progenitor cells.

James A, Thottappillil N, Peault B, Zhang X Front Cell Dev Biol. 2023; 11:1289438.

PMID: 37786809 PMC: 10541955. DOI: 10.3389/fcell.2023.1289438.

References
1.
Xu J, Wang Y, Gomez-Salazar M, Hsu G, Negri S, Li Z . Bone-forming perivascular cells: Cellular heterogeneity and use for tissue repair. Stem Cells. 2021; 39(11):1427-1434. PMC: 8830593. DOI: 10.1002/stem.3436. View

2.
Xu J, Wang Y, Hsu C, Negri S, Tower R, Gao Y . Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells. Elife. 2020; 9. PMC: 7550188. DOI: 10.7554/eLife.58990. View

3.
Xu J, Li D, Hsu C, Tian Y, Zhang L, Wang Y . Comparison of skeletal and soft tissue pericytes identifies CXCR4 bone forming mural cells in human tissues. Bone Res. 2020; 8(1):22. PMC: 7244476. DOI: 10.1038/s41413-020-0097-0. View

4.
Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H . ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis. PLoS One. 2013; 8(6):e65158. PMC: 3675199. DOI: 10.1371/journal.pone.0065158. View

5.
Shaw I, OSullivan E, Pisco A, Borthwick G, Gallagher K, Peault B . Aging modulates the effects of ischemic injury upon mesenchymal cells within the renal interstitium and microvasculature. Stem Cells Transl Med. 2021; 10(8):1232-1248. PMC: 8284778. DOI: 10.1002/sctm.20-0392. View